Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Cannabis and Cannabinoids Institute (ICCI) is a multidisciplinary research and educational hub located in Prague, Czech Republic. Founded as a joint venture between patient advocacy groups and private investment, the institute focuses on the scientific research of cannabis and its therapeutic applications. ICCI provides services including clinical trial design, chemical analysis, regulatory consulting, and product certification to the global cannabis industry. By collaborating with international universities and government agencies, the institute aims to standardize cannabis-based treatments and integrate them into mainstream healthcare systems. The organization serves as a bridge between patients, physicians, and the pharmaceutical industry to ensure evidence-based access to cannabinoid therapies. Its work encompasses various medical fields, including neurology, oncology, and pain management, through the study of the endocannabinoid system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Cannabis and Cannabinoids Institute.